Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-11-01
|
Series: | Protein & Cell |
Online Access: | http://link.springer.com/article/10.1007/s13238-017-0489-0 |